Top compounds associated with response to CLTA


Feature Type Standardized
Nominal ANOVA
mRNA AS605240 GDSC1000 pan-cancer AAC 0.071 0.03
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.11 0.03
mRNA PF-4708671 GDSC1000 pan-cancer AAC -0.074 0.03
mRNA Doxorubicin gCSI pan-cancer AAC 0.11 0.03
mRNA GDC-0941 gCSI pan-cancer AAC 0.13 0.03
mRNA Rapamycin GDSC1000 pan-cancer AAC -0.11 0.03
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.092 0.03
mRNA Cyclopamine GDSC1000 pan-cancer AAC -0.11 0.03
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.073 0.03
mRNA Imatinib GDSC1000 pan-cancer AAC -0.11 0.04
Download CSV